Themipyrnom 0.2 mg Injection 1 ml is used to reduce secretions from the mouth, throat, or stomach (such as saliva or stomach acid), to avoid cardiac rhythm issues during anesthesia, intubation, or surgery, or to minimize side effects from specific medications (such as pyridostigmine and neostigmine).

Themipyrnom 0.2 mg Injection 1 ml contains 'Glycopyrrolate', which works by inhibiting the action of acetylcholine. Thus, reduces gastric secretions' volume and free acidity and controls excessive pharyngeal, bronchial, and tracheal secretions.

Themipyrnom 0.2 mg Injection 1 ml will be administered by a healthcare professional; do not self-administer. In some cases, Themipyrnom 0.2 mg Injection 1 ml may cause dry mouth, urinary retention and hesitancy, blurred vision, palpitations, and decreased sweating. Most of these side effects of Themipyrnom 0.2 mg Injection 1 ml do not require medical attention and gradually resolve over time. However, if the side effects persist or worsen, please consult your doctor.

Inform your doctor if you are allergic to any components in Themipyrnom 0.2 mg Injection 1 ml. Consult your doctor if you are pregnant or breastfeeding. Themipyrnom 0.2 mg Injection 1 ml may cause drowsiness and blurred vision, do not drive or operate machinery unless you are alert. Let your doctor know if you are taking prescription and non-prescription medications, including vitamins and herbal supplements.

Themipyrnom 0.2 mg Injection 1 ml is used to treat various medical conditions. The detailed uses are as follows:

• Reduction of preoperative secretions: It decreases saliva, tracheobronchial, and pharyngeal secretions to help maintain a clear airway during surgery.
• Prevention and treatment of intraoperative bradycardia: It helps manage a slow heart rate during anaesthesia or surgical procedures.
• Adjunct to anaesthesia: It minimises airway secretions and suppresses certain reflexes during anaesthesia, improving surgical safety and patient comfort.

• Themipyrnom 0.2 mg Injection 1 ml is administered by a qualified healthcare professional, typically in a hospital or clinic setting.
• Your doctor will determine the appropriate dose and frequency based on your medical condition.
• Follow your healthcare provider's instructions about the medication and any steps to track your progress or precautions during treatment.

• Themipyrnom 0.2 mg Injection 1 ml contains Glycopyrrolate, which belongs to the group of medicines called anticholinergics.
• Used during anaesthesia to reduce airway and gastric secretions, including the volume and acidity of gastric secretions.
• Helps block cardiac inhibitory reflexes during induction of anaesthesia and intubation.
• Used during surgery to manage arrhythmias caused by surgery, drugs, or vagal reflexes.
• Protects against peripheral muscarinic effects of cholinergic agents.
• Also used as adjunct therapy for treating peptic ulcers when an immediate anticholinergic effect is needed or when oral medication is not possible.
• Works by inhibiting acetylcholine, thereby reducing gastric acidity and controlling excessive pharyngeal, bronchial, and tracheal secretions.

• Inform your doctor if you are allergic to any medicines or foods.
• Before receiving this injection, tell your doctor if you have any medical conditions such as glaucoma, bowel or bladder blockage, heart disease, irregular heartbeat, heart failure, high blood pressure, overactive thyroid, kidney or liver problems, muscle weakness, severe ulcerative colitis, toxic megacolon, or if you are very weak.
• Let your doctor know if you are pregnant, planning to become pregnant, or breastfeeding.
• Inform your doctor about all prescription and non-prescription medicines, vitamins, supplements, and herbal products you are taking to avoid interactions.
• This medicine should be given only by a healthcare professional in a clinical setting where monitoring is available.